Skip to main content
SpringerLink
Log in

Kein Überlebensvorteil durch 5-FU-basierte adjuvante Chemotherapie

Nach präoperativer RCT bei lokal fortgeschrittenem Rektumkarzinom

  • journal club
  • Published:
Info Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Sauer R et al. N Engl J Med. 2004;351(17):1731–1740.

    Article  CAS  PubMed  Google Scholar 

  2. Sauer R et al. J Clin Oncol. 2012;30(16):1926–1933.

    Article  CAS  PubMed  Google Scholar 

  3. Moertel CG et al. N Engl J Med. 1990;322(6):352–358.

    Article  CAS  PubMed  Google Scholar 

  4. André T et al. J Clin Oncol. 2009;27(19):3109–3116.

    Article  PubMed  Google Scholar 

  5. Köhne CH et al. Ann Oncol. 2002;13(2):308–317.

    Article  PubMed  Google Scholar 

  6. Cancer Genome Atlas Network. Nature. 2012;487(7407):330–337.

    Article  Google Scholar 

  7. Fietkau R et al. Int J Radiat Oncol Biol Phys. 2007;67(4):1008–1019.

    Article  PubMed  Google Scholar 

  8. Rödel C et al. J Clin Oncol. 2014;32(5s, Suppl):Abstr 3500.

    Google Scholar 

  9. Schrag D et al. J Clin Oncol. 2014;32(6):513–518.

    Article  CAS  PubMed  Google Scholar 

  10. Chua YJ et al. Lancet Oncol. 2010;11(3):241–248.

    Article  CAS  PubMed  Google Scholar 

Literatur

  • Erstpubliziert in Strahlenther Onkol. 2014;190(8):772–773.

    Google Scholar 

Originalie

  • Bosset JF et al. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. Lancet Oncol. 2014;15(2):184–190.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Radio-Onkologie, Universitätsspital Zürich, Zürich, Schweiz

    Matthias Guckenberger

Authors
  1. Matthias Guckenberger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthias Guckenberger.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guckenberger, M. Kein Überlebensvorteil durch 5-FU-basierte adjuvante Chemotherapie. Info Onkol. 17, 17–19 (2014). https://doi.org/10.1007/s15004-014-0967-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-014-0967-y

Schlüsselwörter:

Search

Navigation